Seeport » MarketPlace
IPC:G01N 33
NAICS:621511

Specific Diagnostic Detection by Limited Primer Extension

Atom Sciences, Inc.
  • Technology Description

    Atom Sciences has developed a new nucleic acid amplification approach to diagnostics that relies on helicase driven iterative primer extension reactions (HDIE). It has been applied in the identification of human pathogens.

  • Value Proposition

    Atom Sciences has a unique platform for pathogen typing that may replace current diagnostic strategies. Individual species of bacteria or viruses, along with specific genes in the pathogen can be identified and quantified, thereby increasing the accuracy of the consequent therapy. Unlike PCR approaches, the technology is less sensitive to contamination because of its high specificity. In addition, the technology amplifies the target nucleic acid linearly, leading to quantitative analysis, but retaining the high sensitivity required for detecting and identifying infectious and growing microorganisms.

  • Market Projection

    88?rand=399057
    2008 2009 2010 2011 2012
    Market Size $3735939.0 $4036687.0 $4361649.0 $4712774.0 $5092169.0
    Market Share (%) 13.0% 30.0% 94.0% 94.0% 94.0%
  • Competitive Analysis

    87?rand=315720
  • Commercialization Team

  • Company Capsule

    Atom Sciences, Inc.

    114 Ridgeway Center
    Oak Ridge, TN 37830
    USA

    Atom Sciences, Inc. (ASI) is a privately held, high-tech corporation located at 114 Ridgeway Center, Oak Ridge, Tennessee, 37830-8810 USA. The company was incorporated in January of 1981 to commercialize Resonance Ionization (RI), a laser-based technology initially developed at Oak Ridge National Laboratory by Dr. G. S. Hurst and coworkers. The initial work in characterization of materials has expanded to include biotechnology applications of RI and this has further led to non-RI biotechnology projects.

  • Video Introduction